Dec 6- U.S. regulators on Friday approved Gilead Sciences Inc's Sovaldi, also known as sofosbuvir, as a potential cure for chronic infection with the liver-destroying hepatitis C virus. Most patients will be treated with the $7,000- a-week drug for 12 weeks, resulting in a total price of $84,000, according to Gilead spokeswoman Cara Miller.» Read More
Ping Li of Accel Partners discusses the company's investment in next-generation data-based technology, including Cloudera, Nimble Storage and Sumo Logic.
The IKEA Foundation, the philanthropic arm of the iconic Swedish furniture maker, has helped come up with a more comfortable refugee shelter.
Microsoft has announced a major policy change on the Xbox One, bowing to consumer sentiment.
President Obama will target carbon emissions from power plants as part of a climate change agenda expected to be rolled out in the next few weeks.
*U.S. still searching for source of biotech wheat in Oregon. WASHINGTON, June 19- An executive with Monsanto Co and two other pioneers in agricultural biotechnology said their selection as winners of the $250,000 World Food Prize on Wednesday should encourage the wider use of genetically engineered crops.
Ouya founder and CEO Julie Uhrman discusses how her company's $99 gaming console could give PlayStation and Xbox a run for their money by allowing developers to publish game apps to the television.
A squirrel census? A bug-killing gun? These are successful projects on crowdfunding sites, which are expected to raise $5 billion this year.
The world's largest solar boat reached New York City Monday afternoon, docking at the North Cove Marina in downtown Manhattan. New York is the boat's sixth stop.
Sam Shank, CEO of HotelTonight, explains how its new app lets impulsive travelers and procrastinators book same-day hotel reservations from their mobile phones and at a discount.
Nitin Nohria, Harvard Business School dean, discusses how the nation is likely to build the next generation of workers.
LONDON, June 18- AstraZeneca has chosen a science park on the southern outskirts of Cambridge, England, next to the world-renowned Addenbrooke's Hospital, for its new $500 million global headquarters and research centre.
Despite the outrage over allegations the NSA is collecting data on every phone call, it is clear that the worst privacy violations, especially for businesses, start with you.
Netflix said a multi-year agreement with Dreamworks is its biggest deal ever for original first-run content and includes more than 300 hours of new programming.
Last year $2 billion worth of products were sold with a label saying they do not contain ingredients from genetically modified organisms, but the claim wasn't backed by regulators.
The call of dessert can be hard to ignore. CNBC Prime presents 10 small businesses offering something sinfully delicious, for those times when willpower abandons you.
Entrepreneurs and investors are betting on a future full of flying robots that can do anything from survey crops to make a delivery.
Sylvain Preumont, founder and director of iMAKR, the world's largest 3-D printing store, tells CNBC how the printers work.
3D printing has arrived on the Squawk Box set, where the anchors took the opportunity to create models of their own heads.
*Myriad Genetics shares rise after ruling, then fall. WASHINGTON, June 13- A unanimous U.S. Supreme Court on Thursday prohibited patents on naturally occurring human genes but allowed legal protections on synthetically produced genetic material in a compromise ruling hailed as a partial victory for patients and the biotechnology industry.
*Myriad Genetics shares up more than 10 percent after ruling. WASHINGTON, June 13- In a first of its kind ruling on human genes, a unanimous U.S. Supreme Court on Thursday decided that synthetically produced genetic material can be patented but naturally occurring DNA extracted from the human body cannot.